The level of competition, not price, determines drug rebates, contends America's Health Insurance Plans. Big pharma is largely responsible for rising drugs prices, AHIP said, citing the results from a ...
Theranos CEO Elizabeth Holmes told attendees at the America's Health Insurance Plans annual meeting last week that direct-to-consumer lab testing is key to health reform and a way to reduce disease ...
Out-of-network providers that charge more for COVID-19 tests are performing a greater share of them during this phase of the pandemic, leading to rising expenses among health insurance companies, the ...
LAS VEGAS—Biosimilars hold significant promise in reducing pharmacy costs, and pharmacy benefit managers have touted them for years as being the key to introducing competition to some of the most ...
UHG spokesman Matt Stearns said, “UnitedHealth Group believes the interest of our company and the customers we serve are no longer best represented by AHIP and accordingly are ending our membership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback